Crain’s Cleveland Business: A company founded by and based on the research findings of Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, and Drew Adams, the Thomas F. Peterson Jr. Professor of Novel Therapeutics, recently partnered with Genentech to develop new medications for patients with neurological disorders.
